Clinical Trials Logo

Clinical Trial Summary

The study objectives are : Determine standards of plasma levels of casein-specific immunoglobulin G4 (IgG4) and egg-specific immunoglobulin G4 (IgG4) as a function of age, in non-allergic children, in allergic children, and in cured former allergic patients. Analyze the plasma IgG4 / IgE ratio, according to the result of the oral provocation test (tolerance versus allergy) and, in the event of a reaction, according to the reactogenic dose (dose which caused the reaction).Determine whether analysis of the plasma metabolome can identify children with a cured allergy to cow's milk protein or to egg from those with a persistent allergy.


Clinical Trial Description

Immunoglobulin E (IgE) mediated allergies to cow's milk and hen's egg affects 2-3% and 0.5-2.5% of children respectively. These allergies expose to the risk of immediate anaphylactic reaction that may be life-threatening. Approximately 70-80% of children with IgE mediated allergies to cow's milk and hen's egg will tolerate these foods by the age of 6 years. However, in the absence of reliable biomarker of tolerance, to determine whether oral tolerance is obtained, it is recommended to perform an oral food challenge (OFC) in a hospital setting. This procedure is expensive, time consuming, and carries the risk of anaphylactic reactions. Many studies have tried to find predictive markers of reactivity during the OFC. Improving the prediction of the response to OFC would be very useful to better select children in whom an OFC can be performed without risk to confirm the acquisition of tolerance. For instance, serum specific IgE positive values beyond which 95% of patients would have an allergic reaction have been proposed. These values are highly variable from one study to another because of methodological differences and heterogeneity of populations, and cannot be used in clinical practice. The regular dosage of serum specific IgE and its evolution over time is used in clinical practice to predict a possible persistence of IgE mediated food allergy. Indeed, an initial high rate and/or elevation of specific IgE levels may be predictive of a persistent allergy, while initial low rates and a decrease in specific IgE may predict tolerance. When tolerance develops, there is a decrease in specific IgE levels, however, even if tolerance is obtained, they can remain positive at pathological levels. During continuous exposure to an allergen, the specific immunoglobulin G4 (IgG4) response is physiological. Oral immunotherapy studies in food allergies showed an elevation of specific IgG4, associated with an elevation in the number of regulatory T lymphocytes (LTreg) and the production of interleukin (IL)-10. The development of spontaneous oral tolerance, without the intervention of immunotherapy, also seems to involve IgG4. In a prospective follow-up of a cohort of children with an IgE-mediated cow's milk allergy, the elevation of specific IgG4 was observed in those who cure of their allergy, with rates higher than those observed in children whose allergy persists. In children with cow's milk and/or egg allergies, a low concentration of specific (IgG4 of B-Lactoglobulin or ovalbumin is associated with the need for a more prolonged exclusion diet. The balance between specific IgE and IgG4 therefore appears to be important in the development of tolerance and may reflect the balance between effector T cells and LTreg. However, the normal serum levels of IgG4 to cow's milk and hen's egg are unknown. A recently published study of Doctor Guillaume Lezmi and Professor Karine Adel-Patient shows that children with an IgE-mediated allergy to cow's milk protein and those who outgrew this allergy, have distinct plasma metabolomic signature. This suggests that plasma metabolomic analysis may be a useful too to differentiate children with a persistent cow's milk protein allergy from those who acquired tolerance to cow's milk. If confirmed, the metabolic signature may be useful to better identify children to whom an oral food challenge with cow's milk protein could be propose. These results need to be confirmed in a larger population and in other food allergies. The study objectives are : Determine standards of plasma levels of casein-specific immunoglobulin G4 (IgG4) and egg-specific immunoglobulin G4 (IgG4) as a function of age, in non-allergic children, in allergic children, and in cured former allergic patients. Analyze the plasma IgG4 / IgE ratio, according to the result of the oral provocation test (tolerance versus allergy) and, in the event of a reaction, according to the reactogenic dose (dose which caused the reaction). Determine whether analysis of the plasma metabolome can identify children with a cured allergy to cow's milk protein or to egg from those with a persistent allergy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03776474
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Guillaume Lezmi, MD, PhD
Phone +33 1 44 49 48 38
Email guillaume.lezmi@aphp.fr
Status Recruiting
Phase
Start date November 18, 2020
Completion date November 18, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05839405 - Food Allergy in the Brain
Completed NCT04378335 - Assessment of Orality Disorders in Children With Food Allergies N/A
Completed NCT05794568 - Evaluate the Efficacy of the OITcontrol Application. N/A
Active, not recruiting NCT05165329 - A Randomized, Controlled Trial of Probiotic and Peanut Oral Immunotherapy (PPOIT) in Inducing Tolerance in Hong Kong Children With Peanut Allergy Compared With Oral Immunotherapy (OIT) Alone and With Placebo N/A
Completed NCT05093114 - Friends, Family & Food: Food Allergy App for Youth ( F3A-App )
Recruiting NCT05406141 - Nutrition Sufficiency, Allergy Efficacy and Safety of Neocate Jr in Children With Food Protein Allergy N/A
Completed NCT05111938 - Friends, Family & Food: Food Allergy App for Youth - II N/A
Recruiting NCT06034678 - Evaluation of The Food Allergy Mastery Program N/A
Recruiting NCT06467994 - Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children Phase 2
Not yet recruiting NCT04407104 - Allergy to Almond in Children
Enrolling by invitation NCT05287074 - The Significance of a Timely Food Allergy Diagnosis and Optimal Surveillance of Nutritional Status in Children
Enrolling by invitation NCT04955132 - Impact of E-learning on Parental Confidence in Managing Food Allergy N/A
Active, not recruiting NCT05590299 - Fish Oral Immunotherapy in Hong Kong Children N/A
Recruiting NCT03309488 - Basophil Activation Test to Diagnose Food Allergy
Recruiting NCT05707858 - The Naples Pediatric Food Allergy (NAPFA) Score
Suspended NCT04198753 - Skin Characteristics of Parents of Food Allergic Pediatric Patients
Recruiting NCT05309772 - The Clinical Impact of the Basophil Activation Test to Diagnose Food Allergy N/A
Recruiting NCT04376242 - Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge N/A
Completed NCT04770727 - CBT Group Intervention for Children With Food Allergy and Anxiety N/A
Completed NCT04512924 - The Psychosocial Outcomes in Caregivers of Children With Food Allergy N/A